HOOK (HOOKIPA Pharma) Short Percentage of Float


HOOK HOOKIPA Pharma Inc HOOK
49 GF Score
Price $1.15
GF Value $2.78
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is HOOKIPA Pharma Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HOOK vs LNAI, ZEOX, GDTC: Short Percentage of Float Comparison

For the Biotechnology subindustry, HOOKIPA Pharma's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HOOKIPA Pharma Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HOOKIPA Pharma's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where HOOKIPA Pharma's Short Percentage of Float falls into.


HOOK
49GF Score
HOOKIPA Pharma Inc HOOK
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is HOOKIPA Pharma (HOOK) Overvalued in 2026?

Based on GuruFocus' analysis, HOOKIPA Pharma stock appears to be undervalued. The current stock price of $1.15 is trading 58.6% below its estimated GF Value™ of $2.78. GuruFocus considers HOOKIPA Pharma to be Possible Value Trap.

Key valuation signals for HOOK:

  • Short Percentage of Float:
  • GF Value™: $2.78 vs. price of $1.15 (58.6% below fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the HOOK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HOOKIPA Pharma Business Description

Address 350 Fifth Avenue, 72nd Floor, Suite 7240, New York, NY, USA, 10118
HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. The company's product candidates are designed to induce specific, robust and durable CD8+ T cells and antibodies to eliminate cancers and serious infectious diseases. Its pipeline includes biological therapies for oncology, targeting human papillomavirus type 16-positive (HPV16+) cancers, KRAS mutated cancers, and other targets. In addition, It is also focused to develop therapies that are intended to provide functional cures for hepatitis B virus (HBV) and human immunodeficiency virus-1 (HIV-1).
49GF Score

Get the complete analysis for HOOK

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.15
Price
$2.78
GF Value